Literature DB >> 10471050

DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers.

H Iwase1, Y Omoto, H Iwata, T Toyama, Y Hara, Y Ando, Y Ito, Y Fujii, S Kobayashi.   

Abstract

Oestrogen receptor alpha (ER-alpha) gene has two specific promoters, distal (P0) and proximal (P1), which induce almost identical transcripts in size due to different splicing. We examined the methylation at both promoter regions of the ER-alpha gene using HpaII, a methylation-sensitive restriction enzyme, prior to polymerase chain reaction (PCR) amplification. To confirm the results of PCR-based methylation analysis, Southern hybridization was also performed. Twenty of 29 patients with ER-alpha-positive tumours and five of 27 with ER-alpha-negative tumours were unmethylated at the P1 promoter region of the ER-alpha gene. The incidence of methylation was highly negatively correlated with ER-alpha expression (P = 0.0002). A similarly negative correlation was observed at the P0 promoter region of the ER-alpha gene (P = 0.0154). Additionally, the tumours with the ER-alpha gene hypermethylated at both promoter regions had definitely negative ER-alpha values. It was suggested that this epigenetic change might control ER-alpha expression, and might play an important role in the loss of hormone-dependence in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471050      PMCID: PMC2374276          DOI: 10.1038/sj.bjc.6690631

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Oestrogen receptor gene structure and function in breast cancer.

Authors:  C K Watts; M L Handel; R J King; R L Sutherland
Journal:  J Steroid Biochem Mol Biol       Date:  1992-03       Impact factor: 4.292

2.  Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.

Authors:  M Gonzalez-Zulueta; C M Bender; A S Yang; T Nguyen; R W Beart; J M Van Tornout; P A Jones
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

3.  Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells.

Authors:  Y L Ottaviano; J P Issa; F F Parl; H S Smith; S B Baylin; N E Davidson
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

Review 4.  Estrogen receptor variants in clinical breast cancer.

Authors:  W L McGuire; G C Chamness; S A Fuqua
Journal:  Mol Endocrinol       Date:  1991-11

5.  Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.

Authors:  S R Johnston; G Saccani-Jotti; I E Smith; J Salter; J Newby; M Coppen; S R Ebbs; M Dowsett
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

6.  Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines.

Authors:  K Grandien; M Bäckdahl; O Ljunggren; J A Gustafsson; A Berkenstam
Journal:  Endocrinology       Date:  1995-05       Impact factor: 4.736

7.  Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression.

Authors:  A T Ferguson; R G Lapidus; S B Baylin; N E Davidson
Journal:  Cancer Res       Date:  1995-06-01       Impact factor: 12.701

8.  Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.

Authors:  G Hennig; J Behrens; M Truss; S Frisch; E Reichmann; W Birchmeier
Journal:  Oncogene       Date:  1995-08-03       Impact factor: 9.867

9.  Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.

Authors:  N Roodi; L R Bailey; W Y Kao; C S Verrier; C J Yee; W D Dupont; F F Parl
Journal:  J Natl Cancer Inst       Date:  1995-03-15       Impact factor: 13.506

10.  Loss of heterozygosity of the oestrogen receptor gene in breast cancer.

Authors:  H Iwase; J M Greenman; D M Barnes; L Bobrow; S Hodgson; C G Mathew
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more
  17 in total

Review 1.  Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.

Authors:  David K Lung; Rebecca M Reese; Elaine T Alarid
Journal:  Horm Cancer       Date:  2020-06-26       Impact factor: 3.869

2.  The epigenetic silencing of the estrogen receptor (ER) by hypermethylation of the ESR1 promoter is seen predominantly in triple-negative breast cancers in Indian women.

Authors:  Jyothi S Prabhu; Kanu Wahi; Aruna Korlimarla; Marjorrie Correa; Suraj Manjunath; N Raman; B S Srinath; T S Sridhar
Journal:  Tumour Biol       Date:  2012-02-24

Review 3.  Breast cancer - one term, many entities?

Authors:  Nicholas R Bertos; Morag Park
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

4.  Loss of estrogen receptor 1 enhances cervical cancer invasion.

Authors:  Yali Zhai; Guido T Bommer; Ying Feng; Alexandra B Wiese; Eric R Fearon; Kathleen R Cho
Journal:  Am J Pathol       Date:  2010-06-25       Impact factor: 4.307

Review 5.  Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer.

Authors:  L Yan; X Yang; N E Davidson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

6.  Association of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinoma.

Authors:  De-Tao Yin; Lin Wang; Jianrui Sun; Fengyan Yin; Qingtao Yan; Rulong Shen; Gang He; Jian-Xin Gao
Journal:  Int J Clin Exp Pathol       Date:  2010-05-25

7.  DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations.

Authors:  Mia M Gaudet; Mihaela Campan; Jonine D Figueroa; Xiaohong R Yang; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; David L Rimm; Peter W Laird; Montserrat Garcia-Closas; Mark E Sherman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-27       Impact factor: 4.254

8.  Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway.

Authors:  Shangqin Guo; Gail E Sonenshein
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

9.  Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk.

Authors:  Sonia S Maruti; Cornelia M Ulrich; Emily White
Journal:  Am J Clin Nutr       Date:  2008-12-30       Impact factor: 7.045

Review 10.  Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment response.

Authors:  Thushangi N Pathiraja; Vered Stearns; Steffi Oesterreich
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-01-27       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.